Validation Study of the EMILY AI Device in Acute and Chronic Respiratory Failure

Currently, there is no holistic solution for patients with respiratory diseases that includes oxygenation and management of a patient with respiratory disease, combining dynamic and automatic O2 administration and the detection of clinical worsening, generating a diagnostic suspicion, a management proposal, and notifying the medical team. For device validation, prospective studies will be conducted in patients in respiratory intermediate care units, conventional hospitalization, during physical activity in the hospital setting, and in an out-of-hospital setting. The device will be evaluated in terms of oxygenation efficacy, response time, patient safety, efficiency, versatility, clinical benefit, and adaptability.

NCT Number	NCT06952816
Lead Sponsor	Aether Tech S.L. Collaborators: Hospital Universitario Fundación Jiménez Díaz, Hospital Clinic of Barcelona
Conditions	Chronic Respiratory Failure, Acute Respiratory Failure
Enrollment	20 participants
Start Date	2025-04-23
Primary Completion	2025-06-30 (estimated)
Study Completion	2026-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-09